Beam Therapeutics Is A Biotechnology Company Located In Cambridgemassachusettsfounded In 2017The Company Specializes In Gene Therapies And Genome Editingparticularly Through Its Innovative Base Editing Technologiesco Founded By Notable Scientists In The Crispr Fieldbeam Therapeutics Is Dedicated To Developing Precision Genetic Medicines Aimed At Treating Serious Diseases Such As Sickle Cell Diseaset Cell Cancersglycogen Storage Disease 1Aand Alpha 1 Antitrypsin Deficiency The Companyae S Pipeline Includes Investigational Products Like Beam 101Which Targets Sickle Cell Diseasealong With Other Products Focused On Genetic Disordersbeam Therapeutics Employs Various Genome Editing Toolsincluding Cytosine And Adenine Base Editorsto Provide Precise Modifications To Dna And Rnathe Company Is Publicly Traded On Nasdaq Under The Ticker Symbol Beam And Has Raised Significant Funding To Support Its Research And Development Effortswith A Growing Team Of Around 483 Employeesbeam Therapeutics Is Committed To Delivering Lifelong Cures To Patients Through Its Cutting Edge Science And Collaborative Partnerships
